Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Kalla Vyas, Arpita ^a   Yang, Kai Chien ^a   Woo, Dennis ^a   Tzekov, Anatoly ^a   Kovacs, Attila ^a   Jay, Patrick Y ^a   Hruz, Paul W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; DEOXYGLUCOSE; EXENDIN 4; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; PROTEIN KINASE B; RITONAVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERMITTENT THERAPY; ENZYME PHOSPHORYLATION; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HEART MUSCLE CONTRACTILITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PREDICTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE DRUG DOSE; SURVIVAL TIME;

ANIMALIA; MURINAE; MUS;

EID: 79951979265     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017178     Document Type: Article

References (28)

1. Shah A, Shannon RP, (2003) Insulin resistance in dilated cardiomyopathy. Rev Cardiovasc Med 4 (Suppl 6): S50-57.
2. Witteles RM, Fowler MB, (2008) Insulin-Resistant Cardiomyopathy: Clinical Evidence, Mechanisms, and Treatment Options. Journal of the American College of Cardiology 51: 93-102.
3. Ashrafian H, Frenneaux MP, Opie LH, (2007) Metabolic Mechanisms in Heart Failure. Circulation 116: 434-448.
4. Hausenloy DJ, Yellon DM, (2008) GLP-1 Therapy: Beyond Glucose Control. Circ Heart Fail 1: 147-149.
5. Grieve DJ, Cassidy RS, Green BD, (2009) Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control? Br J Pharmacol 157: 1340-1351.
6. Asmar M, Holst JJ, (2010) Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. Curr Opin Endocrinol Diabetes Obes 17: 57-62.
7. Sokos GG, Nikolaidis LA, Mankad S, Elahi D, Shannon RP, (2006) Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail 12: 694-699.
8. Hausenloy DJ, Yellon DM, (2008) GLP-1 therapy: beyond glucose control. Circ Heart Fail 1: 147-149.
9. Buerger A, Rozhitskaya O, Sherwood MC, Dorfman AL, Bisping E, et al. (2006) Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J Card Fail 12: 392-398.
10. Hruz PW, Yan Q, Struthers H, Jay PY, (2008) HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy. FASEB J 22: 2161-2167.
11. McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, et al. (2007) Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 104: 612-617.
12. Smith SA, Young P, Cawthorne MA, (1986) Quantification in vivo of the effects of insulin on glucose utilization in individual tissues of warm- and cold-acclimated rats. The Biochemical Journal 237: 789-795.
13. Hom FG, Goodner CJ, Berrie MA, (1984) A [3H]2-deoxyglucose method for comparing rates of glucose metabolism and insulin responses among rat tissues in vivo. Validation of the model and the absence of an insulin effect on brain. Diabetes 33: 141-152.
14. Peterson LR, Herrero P, McGill J, Schechtman KB, Kisrieva-Ware Z, et al. (2008) Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes. Diabetes 57: 32-40.
15. Rodrigues B, Cam MC, McNeill JH, (1995) Myocardial substrate metabolism: implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27: 169-179.
16. Schwenk RW, Luiken JJFP, Bonen A, Glatz JFC, (2008) Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovascular Research 79: 249-258.
17. Rosenblatt-Velin N, Montessuit C, Papageorgiou I, Terrand J, Lerch R, (2001) Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism. Cardiovasc Res 52: 407-416.
18. Morissette MR, Howes AL, Zhang T, Heller Brown J, (2003) Upregulation of GLUT1 expression is necessary for hypertrophy and survival of neonatal rat cardiomyocytes. Journal of Molecular and Cellular Cardiology 35: 1217-1227.
19. Mulder P, Thuillez C, (2006) Heart rate slowing for myocardial dysfunction/heart failure. Adv Cardiol 43: 97-105.
20. Denissen JF, Grabowski BA, Johnson MK, Buko AM, Kempf DJ, et al. (1997) Metabolism And Disposition of the HIV-1 Protease Inhibitor Ritonavir (ABT-538) in Rats, Dogs, and Humans. Drug Metabolism and Disposition 25: 489-489.
21. Poornima I, Brown SB, Bhashyam S, Parikh P, Bolukoglu H, et al. (2008) Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat. Circ Heart Fail 1: 153-160.
22. Gros R, You X, Baggio LL, Kabir MG, Sadi AM, et al. (2003) Cardiac function in mice lacking the glucagon-like peptide-1 receptor. Endocrinology 144: 2242-2252.
23. Bose AK, Mocanu MM, Carr RD, Yellon DM, (2005) Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model. Cardiovasc Drugs Ther 19: 9-11.
24. Sen P, Mukherjee S, Ray D, Raha S, (2003) Involvement of the Akt/PKB signaling pathway with disease processes. Mol Cell Biochem 253: 241-246.
25. Kahn BB, Alquier T, Carling D, Hardie DG, (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25.
26. Dyck JR, Lopaschuk GD, (2006) AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol 574: 95-112.
27. Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, et al. (2009) Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation 119: 2568-2577.
28. Liang GY, Cai QY, Niu YM, Zheng H, Gao ZY, et al. (2008) Cardiac glucose uptake and suppressed expression/translocation of myocardium glucose transport-4 in dogs undergoing ischemia-reperfusion. Exp Biol Med (Maywood) 233: 1142-1148.